Stay updated on Imvotamab in Non-Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA minor maintenance update was applied, adding Revision v3.4.2 and removing v3.4.1. This change does not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1; no substantive content changes to the study details page were observed. This seems to be an internal version bump rather than a modification to user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedGlossary display was added and page metadata updated to include the Last Update Submitted that Met QC Criteria and revision information (v3.4.0). Minor text adjustments include capitalization changes in 'No FEAR Act data'.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page's Locations section has been expanded and reorganized to include multiple sites across the US and Australia (California, Florida, Kentucky, Massachusetts, New York, Tennessee, Texas, Washington, Victoria, Western Australia, BG, RM) under a unified Locations header, with revision notes indicating version v3.3.3.SummaryDifference1%

- Check91 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous v3.2.0. This change appears to be a site version/update note and does not modify study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Imvotamab in Non-Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.